http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2926368-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41ccfbe314ede0d1286b8319982accae
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N59-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N59-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N59-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-48
filingDate 2016-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8886e4d4c2a99d160395f7e3df1eb1b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a006de98e21335ffd6abd3248a330f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97047bb11f5a0980b8acfd13d8d6affa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_496c1363a6db0f640ac36daca34aa5e3
publicationDate 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2926368-T3
titleOfInvention Use of hydroxyapatite as a carrier of bioactive substances to treat vascular diseases in plants
abstract The object of the invention is a hydroxyapatite vehicle, corresponding to the formula: Ca(10-x)Mx(PO4)(6-y)(CO3)y(OH)2 in which: M is selected from Cu, Mg , Zn, Pb, Cd, Ba, K, Mn, Mo, Fe, Ag, B, Se or a combination of at least two such elements; - x is between 0 and 2, preferably between 0 and 1, more preferably between 0 and 0.8, even more preferably between 0.02 and 0.05; - y is between 0 and 2, preferably between 0 and 1, more preferably between 0.002 and 0.030. Hydroxyapatite is a carrier of a bioactive substance chosen from a metal ion selected from Cu, Zn, S, Mn, Mg, K, Fe, B, Mo, Se and/or an extract of plant origin. Bioactive substances are active in the treatment of vascular diseases of plants, in particular: grapevine yellowing (caused by grapevine phytoplasma), kiwi bacterial canker (caused by Pseudomonas syringae), olive tree decline syndrome (caused by by Xylella fastidiosa) and bacterial Citrus. Canker disease (caused by Xanthomonas axonopodis). (Automatic translation with Google Translate, without legal value)
priorityDate 2015-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53249279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449779460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454118689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449386109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449973617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559351

Total number of triples: 41.